Diasio RB - Search Results

1

Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients.

Ezzeldin HH, Lee AM, Mattison LK, Diasio RB. Ezzeldin HH, et al. Among authors: diasio rb. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8699-705. doi: 10.1158/1078-0432.CCR-05-1520. Clin Cancer Res. 2005. PMID: 16361556

2

Purification and characterization of dihydropyrimidine dehydrogenase from human liver.

Lu ZH, Zhang R, Diasio RB. Lu ZH, et al. Among authors: diasio rb. J Biol Chem. 1992 Aug 25;267(24):17102-9. J Biol Chem. 1992. PMID: 1512248 Free article.

3

Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome.

Harris BE, Carpenter JT, Diasio RB. Harris BE, et al. Among authors: diasio rb. Cancer. 1991 Aug 1;68(3):499-501. doi: 10.1002/1097-0142(19910801)68:3<499::aid-cncr2820680309>3.0.co;2-f. Cancer. 1991. PMID: 1648430

4

Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.

Harris BE, Song R, Soong SJ, Diasio RB. Harris BE, et al. Among authors: diasio rb. Cancer Res. 1990 Jan 1;50(1):197-201. Cancer Res. 1990. PMID: 2293556

5

Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy.

Harris BE, Song RL, He YJ, Soong SJ, Diasio RB. Harris BE, et al. Among authors: diasio rb. Biochem Pharmacol. 1988 Dec 15;37(24):4759-62. doi: 10.1016/0006-2952(88)90349-8. Biochem Pharmacol. 1988. PMID: 3202908

6

Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.

Diasio RB, Beavers TL, Carpenter JT. Diasio RB, et al. J Clin Invest. 1988 Jan;81(1):47-51. doi: 10.1172/JCI113308. J Clin Invest. 1988. PMID: 3335642 Free PMC article.

7

Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy.

Lu Z, Zhang R, Diasio RB. Lu Z, et al. Among authors: diasio rb. Clin Pharmacol Ther. 1995 Nov;58(5):512-22. doi: 10.1016/0009-9236(95)90171-X. Clin Pharmacol Ther. 1995. PMID: 7586945

8

Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy.

Lu Z, Zhang R, Diasio RB. Lu Z, et al. Among authors: diasio rb. Cancer Res. 1993 Nov 15;53(22):5433-8. Cancer Res. 1993. PMID: 8221682

9

Comparison of dihydropyrimidine dehydrogenase from human, rat, pig and cow liver. Biochemical and immunological properties.

Lu ZH, Zhang R, Diasio RB. Lu ZH, et al. Among authors: diasio rb. Biochem Pharmacol. 1993 Sep 1;46(5):945-52. doi: 10.1016/0006-2952(93)90505-q. Biochem Pharmacol. 1993. PMID: 8373446

10

Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy.

Zhang R, Lu Z, Liu T, Soong SJ, Diasio RB. Zhang R, et al. Among authors: diasio rb. Cancer Res. 1993 Jun 15;53(12):2816-22. Cancer Res. 1993. PMID: 8504424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters